US2017042961A1PendingUtilityA1
Methods for treating hcv
Est. expiryDec 20, 2030(~4.4 yrs left)· nominal 20-yr term from priority
Inventors:William E. Delaney, IvJohn O. LinkHongmei MoDavid W. OldachAdrian S. RayWilliam J. WatkinsCheng Yong YangWeidong Zhong
A61P 31/12A61P 43/00A61P 31/14A61K 31/4436A61K 31/7068A61K 31/675A61K 31/7056A61P 1/16A61K 31/5377A61K 31/4025A61K 31/4184A61K 31/4188A61K 31/381A61K 31/407A61K 31/401A61K 31/4178A61K 38/05A61K 45/06A61K 31/40A61K 31/706A61K 38/212A61K 31/662A61K 31/501A61K 31/4353
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
Claims
exact text as granted — not AI-modified1 . A composition comprising two or more compounds selected from Compound 1, Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7:
or a pharmaceutically acceptable salt of Compound 1, Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7,
provided that Compound 1 and Compound 2 are not the only compounds in the composition and further provided that Compound 1 and Compound 3 are not the only compounds in the composition.
2 . The composition of claim 1 which comprises Compound 1 and further comprises a second compound selected from the group consisting of Compound 2, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7.
3 . The composition of claim 2 , wherein the second compound is Compound 4.
4 . The composition of claim 2 , wherein the second compound is Compound 5.
5 . The composition of claim 2 , wherein the second compound is Compound 6.
6 . The composition of claim 1 which comprises Compound 2 and further comprises a second compound selected from the group consisting of Compound 1, Compound 3, Compound 4, Compound 5, Compound 6 and Compound 7.
7 . The composition of claim 6 , wherein the second compound is Compound 4.
8 . The composition of claim 1 which comprises Compound 3 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 4, Compound 5, Compound 6 and Compound 7.
9 . The composition of claim 8 , wherein the second compound is Compound 1.
10 . The composition of claim 8 , wherein the second compound is Compound 5.
11 . The composition of claim 8 , wherein the second compound is Compound 6.
12 . The composition of claim 1 which comprises Compound 4 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 3, Compound 5, Compound 6 and Compound 7.
13 . The composition of claim 12 , wherein the second compound is Compound 1.
14 . The composition of claim 12 , wherein the second compound is Compound 2.
15 . The composition of claim 12 , wherein the second compound is Compound 3.
16 . The composition of claim 12 , wherein the second compound is Compound 6.
17 . The composition of claim 1 which comprises Compound 5 and further comprises a second compound selected from the group consisting of Compound 1, Compound 2, Compound 3, Compound 4, Compound 6 and Compound 7.
18 . The composition of claim 17 , wherein the second compound is Compound 1.
19 . The composition of claim 17 , wherein the second compound is Compound 3.
20 . The composition of claim 17 , wherein the second compound is Compound 6.
21 - 211 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.